Contesting the Obesity ‘Epidemic’: Elements of a Counter Discourse

International Library of Environmental, Agricultural and Food Ethics

Volumn 18, Issue , 2011, Pages 39-57

  van den Belt, Henk ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Diet Pill; Internal Revenue Service; Obese Person; Obesity Research; Primary Pulmonary Hypertension

Indexed keywords

EID: 84880231150     PISSN: 15703010     EISSN: 22151737     Source Type: Book Series    
DOI: 10.1007/978-94-007-0127-4_4     Document Type: Chapter

References (66)

1. Abenhaim, L., Y. Moride, F. Brenot et al. (1996), Appetite-suppressant drugs and the risk of primary pulmonary hypertension, New England Journal of Medicine, 335, 609–616
2. Allison, D.B., K.R. Fontaine, J.E. Manson, J. Stevens and T.B. VanItallie (1999), Annual deaths attributable to obesity in the United States, JAMA, 282, 1530–1538
3. American Obesity Association (2003), Obesity is a chronic disease www.obesity.org/treatment/ obesity.shtml
4. Angell, M. and J.P. Kassirer (1996), Editorial: Editorials and conflicts of interest, New England Journal of Medicine, 335, 1055–1056
5. Angell, M. and A.S. Relman. (2002), Patents, profits & American medicine: conflicts of interest in the testing & marketing of new drugs, Daedalus, 131, 102–111
6. Associated Press (2002), IRS Recognizes Obesity as Disease
7. Associated Press (2004), Fat activists protest diet industry, CNN.com
8. Austin, S.B. (1999), Fat, loathing and public health: The complicity of science in a culture of disordered eating, Culture, Medicine and Psychiatry, 23, 245–268
9. Blair, S.N. and T.S. Church (2004), The fitness, obesity, and health equation: Is physical activity the common denominator? JAMA, 292, 1232–1234
10. Borbély, M. (2001), Is obesity a disease? The Government says yes – until it’s time to pay for treatment, Washington Post
11. Bray, G.A. (2004), Obesity is a chronic, relapsing neurochemical disease, International Journal of Obesity, 28, 34–38
12. Brennan, P. (2002), Feds mull obesity as ‘disease’ – you’ll pay billions, NewsMax.com
13. CNN.com (1996), Anti-obesity drug to get warning. www.cnn.com/HEALTH/9608/22/weight.drug
14. Calle, E.E., C. Rodriguez, K. Walker-Thurmond and M.J. Thun (2003), Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US, Adults, New England Journal of Medicine, 348, 1625–1638
15. Campos, P. (2004), The Obesity Myth: Why America’s Obsession with Weight is Hazardous to Your Health. New York, NY: Gotham Books
16. Campos, P., A. Saguy, P. Ernsberger, E. Oliver and G. Gaesser (2006), The epidemiology of overweight and obesity: Public health crisis or moral panic? International Journal of Epidemiology, 35, 55–60
17. Canguilhem, G. (1978), On the Normal and the Pathological. Dordrecht: Reidel
18. Center for Consumer Freedom (2004), An Epidemic of Obesity Myths. Washington, DC: Center for Consumer Freedom
19. Center for Science in the Public Interest. (2003), Lifting the Veil of Secrecy: Corporate Support for Health and Environmental Professional Associations, Charities, and Industry Front Groups. Washington, DC: Center for Science in the Public Interest
20. Chang, V.W. and N.A. Christakis (2002), Medical modelling of obesity: A transition from action to experience in a 20th century American medical textbook, Sociology of Health & Illness, 24, 151–177
21. Couzin, J. (2005), A heavyweight battle over CDC’s obesity forecasts, Science, 308, 770–771
22. Ernsberger, P. and R.J. Koletsky (1999), Biomedical rationale for a wellness approach to obesity: An alternative to a focus on weight loss, Journal of Social Issues, 55, 221–260
23. Flegal, K.M. et al. (2005), Excess deaths associated with underweight, overweight, and obesity, JAMA, 293, 1861–1873
24. Flegal, K.M., D.F. Williamson, E.R. Pamuk and H.M. Rosenberg (2004), Estimating deaths attributable to obesity in the United States, American Journal of Public Health, 94, 1486–1489
25. Fontaine, K.R., D.T. Redden, C. Wang, A.O. Westfall and D.B. Allison. (2003), Years of Life Lost Due to Obesity, JAMA, 289, 187–193
26. Fraser, L. (1998), Losing It: False Hopes and Fat Profits in the Diet Industry. New York, NY: Plume Books
27. Fumento, M. (2000), Don’t Buy the “Fat Gene” Myth, The New York Post. www.fumento.com/ julyfat.html
28. Fumento, M. (2002), Quick living in the fat lane, Rocky Mountain News. www.fumento.com/ fatlane.html
29. Fumento, M. (2004), Medicare help obesity? Fat chance, Scripps Howard News Service. www. fumento.com/fat/obesity.html
30. Gaesser, G.A. (2003), Is it necessary to be thin to be healthy? Harvard Health Policy Review, 4, 2, 40–47
31. Ginnis, J.M. and W.H. Foege (1993), Actual causes of death in the United States, JAMA, 270, 2207–2212
32. Hajer, M. (2003), Discourse coalitions and institutionalisation of practice: The case of acid rain in Great Britain, In: Fischer F. and J. Forester (eds), The Argumentative Turn in Policy Analysis and Planning. London: UCL Press, 43–76
33. Harris, P. (2004), Fat is fabulous, insist anti-diet protesters. The Observer
34. Healy, D. (2004), Shaping the intimate: Influences on the experience of everyday nerves, Social Studies of Science, 34, 2, 219–245
35. Heshka, S. and D.B. Allison (2001), Is obesity a disease? International Journal of Obesity, 25, 1401–1404
36. Horton, R. (1997), Commentary: Conflicts of interest in clinical research: Opprobrium or obsession? The Lancet, 349, 1112–1113
37. Horton, R. (2004), The dawn of mcscience, New York Review of Books, 51, 4
38. Jeurissen, E. and M. van Spanje (2001), Rondom dik: Zin en onzin over zwaarlijvigheid. Amsterdam: Ambo
39. Klein, R. and M. Fumento (1997), Dialogues: Fat. http://www.slate.com/id/3667/entry/24016 [Accessed October 2010]
40. Krimsky, S. (1999), The profit of scientific discovery and its normative implications, Chicago-Kent Law Review, 75, 15–39
41. Krimsky, S. (2003), Science and the Private Interest. Lanham, MD: Rowman-Littlefield
42. Krimsky, S. (2005), The funding effect in science and its implications for the judiciary, Journal of Law and Policy, 13, 43–68
43. Lexchin, J., L.A. Bero, B. Djulbegovic and O. Clark (2003), Pharmaceutical industry sponsorship and research outcome and quality: Systematic review, BMJ (British Medical Journal), 326, 1167–1179
44. Liebman, A. (2003), Producer’s Notebook: Spin Doctors, Frontline: Dangerous Prescription. www.pbs.org/wgbh/pages/frontline/shows/prescription/etc/notebook.html [Accessed July 2005]
45. Manson, J.E. (1997), Adventures in scientific discourse, Epidemiology, 8, 324–327
46. Manson, J.E. and S.S. Bassuk (2003), Obesity in the United States: A fresh look at its high toll, JAMA, 289, 229–230
47. Manson, J.E. and G.A. Faich (1996a), Editorial: Pharmacotherapy for obesity – do the benefits outweigh the risks? New England Journal of Medicine, 335, 659–660
48. Manson, J.E. and G.A. Faich (1996b), Conflicts of interest – editorialists respond, New England Journal of Medicine, 335, 1064–1065
49. Manson, J.E., W.C. Willett, M.J. Stampfer et al. (1995), Body weight and mortality among women, New England Journal of Medicine, 333, 677–685
50. Mokdad, A.H., J.S. Marks, D.F. Stroup et al. (2004), Actual causes of death in the United States, 2000, JAMA, 291, 1238–1245
51. NIH (1994), National institutes of health national task force on the prevention and treatment of obesity, weight cycling, Journal of the American Medical Association 270, 8, 1196–1202
52. NIH (1996), National institutes of health national task force on the prevention and treatment of obesity, long-term pharmacotherapy in the management of obesity, Journal of the American Medical Association, 276, 23, 1907–1915
53. Saguy, A.C. and K.W. Riley (2005), Weighing both sides: Morality, mortality, and framing contests over obesity, Journal of Health Politics, Policy and Law, 30, 869–921
54. Scott, D. (2003), Science and the consequences of mistrust: Lessons from recent GM controversies, Journal of Agricultural and Environmental Ethics, 16, 569–582
55. Shell, E.R. (2002), The Hungry Gene: The Science of Fat and the Future of Thin. London: Atlantic Books
56. Sismondo, S. (2004), Pharmaceutical maneuvers, Social Studies of Science, 34, 2, 149–159
57. Stein, R. (2003), Is obesity a disease? Insurance, drug access may hinge on answer, Washington Post
58. Stein, R. and C. Connolly. (2004), Medicare changes policy on obesity: Some treatments may be covered, Washington Post
59. Stenson, J. (2003), Can you be both fit and fat? Even with exercise, size may still matter, MSNBC.com. www.msnbc.msn.com/id/3076623 [Accessed July 2005]
60. Stinchcombe, A.L. (2001.), Universities and the Communism of Knowledge as the Core of the World Information Economy.www.sase.org/con2001/papers/stinchcombe.arthur.pdf [Accessed July 2005]
61. Tannahill, A. (1992), Epidemiology and health promotion: A common understanding. In: R. Bunton, and G. Macdonald (eds), Health Promotion: Disciplines and Diversity. New York, NY: Routledge, pp. 86–107
62. Troiano, R.P., E.A. Frongillo, Jr., J. Sobal and D.A. Levitsky (1996), The relationship between body weight and mortality: A quantitative analysis of combined information from existing studies, International Journal of Obesity, 20, 63–75
63. van Kolfschooten, F (2002), Conflicts of interest: Can you believe what you read? Nature, 416, 360–363
64. Visser, M. (1995), Dik voor mekaar: Handreiking voor een breed draagvlak. Haarlem: De Toorts
65. Wann, M. (1999), FAT! SO?: Because You Don’t Have to Apologize for Your Size. Berkley, CA: Ten Speed Press
66. Wolf, A.M. and G.A. Colditz. (1998), Current estimates of the economic costs of obesity in the United States, Obesity Research, 6, 2, 97–106